Biomedical Applications and Toxicity of Nanomaterials

Chapter 1. Macroporous cryogel-based systems for water treatment applications and Safety: nanocomposite-based cryogels and bacteria-based bioreactors.- Chapter 2. One dimensional Semiconducting Nanomaterials: Toxicity and Clinical Applications.- Chapter 3. Prospects of Safe use of Nanomaterials in Biomedicalapplications.- Chapter 4. Hyaluronic acid-based nanotechnologies for delivery and treatment.- Chapter 5. Theranostics nanomaterials for safe cancer treatment.- Chapter 6. Cardiovascular safety assessment of new chemical entities: current perspective and emerging technologies.- Chapter 7. Toxicology of pharmaceutical products during drug development.- Chapter 8. Safety and Risk assessment of food items.- Chapter 9. Non toxic Natural products as regulators of tumour suppressor gene function.- Chapter 10. Advancements in the safety of Plant medicine: Back to nature.- Chapter 11. Chemicals and their interaction in the aquaculture system.- Chapter 12. Zebrafish as a biomedical model to define developmental origins of chemical toxicity.- Chapter 13. Green synthesis of non toxic nanoparticles.- Chapter 14. Synthesis, characterisation and safety of titanium oxide nanoparticles.- Chapter 15. Characterisation of non toxic nanomaterials for biological applications.- Chapter 16. Toxicity assessment of nanoparticle.- Chapter 17. Safety of nanoparticles: emphasis on antimicrobial properties.- Chapter 18. Quantum dots for imaging and its safety.- Chapter 19. Genotoxicity evaluation of nanosized materia.- Chapter 20. Scaffoldmaterials and toxicity.- Chapter 21Biological Safety and Cellular interactions of nanoparticles.- Chapter 22. Role of artificial intelligence in the toxicity prediction of drugs.- Chapter 23. Chemicals and rodent models for the safety study of alzheimer's disease.- Chapter 24. Mitochondria-targeted liposomal delivery in Parkinson's disease: safety concerns.- Chapter 25. Routes of Nano-drug Administration and Nano-based drug delivery system and toxicity.-

Dr. Mohanan is a Fellow of the National Academy of Science and Royal Society of Biologists, UK. He was a JSPS Postdoctoral Fellow at the University of Tsukuba, Japan in the field of Neurotoxicity. He joined Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Govt. of India in 1989. As a toxicologist, he has been intimately associated with all the medical devices/technologies developed at SCTIMST. Currently, he heads the Division of Toxicology. He is a Visiting Professor and Visiting Researcher at Toyo University, Japan, and a Certified Biological Safety Specialist. He received a lifetime achievement award from the Society of Toxicology India, for his outstanding contribution to the field of toxicology. Dr. Mohanan has been teaching toxicology to postgraduates and guiding research scholars. The development of Human-on-a-chip is a new mega project, apart from several other externally funded research projects. He has patented an ELISA kit for the measurement of pyrogenicity and has made significant contributions to the development of medical device regulations in India. He received a certificate of appreciation from the Hon. Minister of Science and Technology, Govt. of India for the contribution to India getting full adherent status on GLP from OECD. He has authored 262 publications and edited 5 books. Presently, He is the Secretary-General of Society of Toxicology, India.

Dr. Sudha Kappalli is a Professor in the Department of Zoology, School of Biological Science, Central University of Kerala. Her research Areas include, Crustacean Growth - Reproduction interaction and its endocrine regulation, biodiversity of parasitic isopods and copepods and host-parasite interaction. She has obtained PhD from University of Calicut in 1993.  She has 27 years of teaching experience at P.G level. Recipient of CAS-PIFI Visiting Scientist Fellowship (2015), CAS-TWAS Visiting Scholar Fellowship (2009 and 2011), Commonwealth